[go: up one dir, main page]

TR200200981T2 - Farmasötik bileşim terkipleri - Google Patents

Farmasötik bileşim terkipleri

Info

Publication number
TR200200981T2
TR200200981T2 TR2002/00981T TR200200981T TR200200981T2 TR 200200981 T2 TR200200981 T2 TR 200200981T2 TR 2002/00981 T TR2002/00981 T TR 2002/00981T TR 200200981 T TR200200981 T TR 200200981T TR 200200981 T2 TR200200981 T2 TR 200200981T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
composition compositions
pharmaceutically acceptable
dosage form
solid dosage
Prior art date
Application number
TR2002/00981T
Other languages
English (en)
Inventor
Heller Rudolf
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200200981(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of TR200200981T2 publication Critical patent/TR200200981T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut bulus, farmasötik açidan kabul görür bir kati dozaj formuna iliskin olup, özelligi agirlik itibariyla en az %5'lik bir dagitici içerigine sahip olmasi ve bu kati dozaj formunun farmasötik açidan kabul görür bir sulu film süspansiyonu ile kapli olmasidir.
TR2002/00981T 1998-11-27 1999-11-20 Farmasötik bileşim terkipleri TR200200981T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98122489 1998-11-27

Publications (1)

Publication Number Publication Date
TR200200981T2 true TR200200981T2 (tr) 2002-06-21

Family

ID=8233041

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2002/00981T TR200200981T2 (tr) 1998-11-27 1999-11-20 Farmasötik bileşim terkipleri
TR2001/01470T TR200101470T2 (tr) 1998-11-27 1999-11-20 Farmasötik bileşim terkipleri.
TR2002/00982T TR200200982T2 (tr) 1998-11-27 1999-11-20 Farmasötik bileşim terkipleri.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2001/01470T TR200101470T2 (tr) 1998-11-27 1999-11-20 Farmasötik bileşim terkipleri.
TR2002/00982T TR200200982T2 (tr) 1998-11-27 1999-11-20 Farmasötik bileşim terkipleri.

Country Status (22)

Country Link
US (3) US6403579B1 (tr)
EP (1) EP1131072B1 (tr)
JP (2) JP2002531395A (tr)
KR (1) KR100421347B1 (tr)
CN (1) CN1184971C (tr)
AR (1) AR020287A1 (tr)
AT (1) ATE238056T1 (tr)
AU (1) AU765977B2 (tr)
BR (1) BR9915610A (tr)
CA (1) CA2352361C (tr)
CO (1) CO5011053A1 (tr)
DE (1) DE69907252T2 (tr)
DK (1) DK1131072T3 (tr)
ES (1) ES2195638T3 (tr)
MY (1) MY121831A (tr)
PE (1) PE20001302A1 (tr)
PT (1) PT1131072E (tr)
TR (3) TR200200981T2 (tr)
TW (1) TWI228414B (tr)
UY (1) UY25821A1 (tr)
WO (1) WO2000032174A2 (tr)
ZA (1) ZA200104280B (tr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
CA2426811A1 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
IN191028B (tr) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
WO2003092622A2 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
CA2492060C (en) * 2002-06-27 2011-11-01 Sb Pharmco Puerto Rico Inc. Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
AU2003251627A1 (en) 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040151772A1 (en) 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
AU2003272851A1 (en) * 2003-09-26 2005-04-14 Shuyi Zhang Sustained release preparation containing hydrochlorothiazide
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
JP2007512372A (ja) 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
WO2005051322A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
HRP20070283T3 (en) * 2003-12-02 2007-11-30 Nicox S.A. Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
EP2281556A1 (en) * 2005-02-25 2011-02-09 F. Hoffmann-La Roche AG Tablets with improved drugs substance dispersibility
US8685452B2 (en) * 2006-06-16 2014-04-01 Lek Pharmaceuticals D.D. Pharmaceutical composition
GB0612540D0 (en) * 2006-06-23 2006-08-02 Novartis Ag Galenical formulations of organic compounds
WO2008114276A1 (en) * 2007-03-16 2008-09-25 Lupin Limited Novel oral controlled release composition of carvedilol
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
EP2544723A2 (en) * 2010-03-10 2013-01-16 Giuliani International Limited Compositions for colon lavage and methods of making and using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2643556B1 (fr) * 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
FI20021701L (fi) * 1991-01-30 2002-09-24 Wellcome Found Veteen dispergoituvia tabletteja
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida

Also Published As

Publication number Publication date
AU1506500A (en) 2000-06-19
EP1131072B1 (en) 2003-04-23
CN1328460A (zh) 2001-12-26
KR20010080578A (ko) 2001-08-22
DK1131072T3 (da) 2003-08-11
ZA200104280B (en) 2002-08-26
CO5011053A1 (es) 2001-02-28
CA2352361C (en) 2007-01-02
US20020052367A1 (en) 2002-05-02
ATE238056T1 (de) 2003-05-15
WO2000032174A2 (en) 2000-06-08
UY25821A1 (es) 2001-07-31
KR100421347B1 (ko) 2004-03-06
JP2007077160A (ja) 2007-03-29
DE69907252T2 (de) 2004-01-29
PT1131072E (pt) 2003-08-29
ES2195638T3 (es) 2003-12-01
EP1131072A2 (en) 2001-09-12
US6403579B1 (en) 2002-06-11
PE20001302A1 (es) 2000-11-30
JP2002531395A (ja) 2002-09-24
BR9915610A (pt) 2001-08-14
MY121831A (en) 2006-02-28
CN1184971C (zh) 2005-01-19
TWI228414B (en) 2005-03-01
DE69907252D1 (de) 2003-05-28
CA2352361A1 (en) 2000-06-08
AU765977B2 (en) 2003-10-09
TR200101470T2 (tr) 2001-11-21
TR200200982T2 (tr) 2002-06-21
AR020287A1 (es) 2002-05-02
US20040087578A1 (en) 2004-05-06
WO2000032174A3 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
TR200200981T2 (tr) Farmasötik bileşim terkipleri
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
TR199700786T1 (tr) Kati aktif madde bilesimleri.
BG106030A (en) Pharmaceutical composition
DK1157037T3 (da) GCSF-konjugater
BR9706897A (pt) Composições antifúngicas com biodisponibilidade aperfeiçoada.
SE9200951D0 (sv) Pharmaceutical composition containing a defined lipid system
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
FI970825A7 (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyö tyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
NL300136I1 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
CY1105437T1 (el) Συνθεσεις πepιεχοντας διφωσφονικα οξεα
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
TR199802769T2 (tr) Terpenoid bilesikler ile antihistaminik bilesiklerin bir kombinasyonunu ihtiva eden topikal bilesim.
FR2729857B1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
TR200402419T4 (tr) Okskarbazepin içeren süspansiyon.
BR9611642A (pt) Compostos composição farmacéutica e processo para a preparação de compostos
DE69833509D1 (de) Benzocycloheptapyridinezusammensetzungen und antineoplastische arzneimittel als kombinationstherapeutika für therapie der zellproliferation
ES2083708T3 (es) Nuevas piperazinilalcoil-3 dihidro-2,3,4h-benzoxazina-1,3 onas-4 sustituidas, su preparacion y su aplicacion en terapeutica.
HUP0102107A2 (hu) Szilárd üzemanyag-adalékok
AU577947B2 (en) Antihypertensive and cardioprotective composition
BR9714047A (pt) Derivados de ácido carboxìlico, uso dos mesmos, combinação destes com um ou mais compostos ativos, preparação de drogas para a administração oral e parenteral, e, antagonista de receptor de endotelina
IL127851A0 (en) Inhibition of TNF activity
ITMI921235A0 (it) Oligonucleotidi antisenso ad attivita' antitumorale, composizioni farmaceutiche li comprendono e loro impieghi